Long Cast Advisers, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, the Portfolio’s cumulative net return ...

Cross Country Healthcare has seen a material decline in their share price, down 60% from the high in November 2022 following the travel nurse industry declines. There's likely still more softness ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Cross Country Healthcare (CCRN) reports results for the quarter ended December 2025. While this widely-known consensus ...

Cross Country Healthcare's stock performance suggests investors expect a challenging period for the company. Long-term tailwinds include high capital turnover, compounding earnings, compressed ...

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q4 2025 Earnings Call Transcript March 4, 2026 Cross Country Healthcare, Inc. misses on earnings expectations. Reported EPS is $-2.56476 EPS, expectations ...

How Healthy Is Cross Country Healthcare's Balance Sheet? The latest balance sheet data shows that Cross Country Healthcare had liabilities of US$283.2m due within a year, and liabilities of US$277.1m ...